Literature DB >> 17250686

Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice.

Gwendolyn Barceló-Coblijn1, Mikhail Y Golovko, Isabella Weinhofer, Johannes Berger, Eric J Murphy.   

Abstract

Because alpha-synuclein (Snca) has a role in brain lipid metabolism, we determined the impact that Snca deletion had on whole brain lipid composition. We analysed masses of individual phospholipid (PL) classes and neutral lipid mass as well as PL acyl chain composition in brains from wild-type and Snca-/- mice. Although total brain PL mass was not altered, cardiolipin and phosphatidylglycerol mass decreased 16% and 27%, respectively, in Snca-/- mice. In addition, no changes were observed in plasmalogen or polyphosphoinositide mass. In ethanolamine glycerophospholipids and phosphatidylserine, docosahexaenoic acid (22 : 6n-3) was decreased 7%, while 16 : 0 was increased 1.1-fold and 1.4-fold, respectively. Surprisingly, brain cholesterol, cholesteryl ester, and triacylglycerol mass were increased 1.1-fold, 1.6-fold, and 1.4-fold, respectively in Snca-/- mice. In isolated myelin, cholesterol mass was also increased 1.3-fold, but because there was also a net increase in myelin PL mass, the cholesterol to PL ratio was unaltered. No changes in the expression of cholesterogenic enzymes were observed, suggesting these did not account for the observed changes in cholesterol. These data extend our previous results in astrocytes and kinetic studies in vivo demonstrating a role for Snca in brain lipid metabolism and demonstrate a clear impact on brain neutral lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250686     DOI: 10.1111/j.1471-4159.2006.04348.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  52 in total

1.  Effects of curvature and composition on α-synuclein binding to lipid vesicles.

Authors:  Elizabeth R Middleton; Elizabeth Rhoades
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis.

Authors:  Ruth Luthi-Carter; David M Taylor; Judit Pallos; Emmanuel Lambert; Allison Amore; Alex Parker; Hilary Moffitt; Donna L Smith; Heike Runne; Ozgun Gokce; Alexandre Kuhn; Zhongmin Xiang; Michele M Maxwell; Steven A Reeves; Gillian P Bates; Christian Neri; Leslie M Thompson; J Lawrence Marsh; Aleksey G Kazantsev
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-08       Impact factor: 11.205

3.  αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction.

Authors:  Becket Greten-Harrison; Manuela Polydoro; Megumi Morimoto-Tomita; Ling Diao; Andrew M Williams; Esther H Nie; Sachin Makani; Ning Tian; Pablo E Castillo; Vladimir L Buchman; Sreeganga S Chandra
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

4.  An improved method for separating cardiolipin by HPLC.

Authors:  Gwendolyn Barceló-Coblijn; Eric J Murphy
Journal:  Lipids       Date:  2008-07-18       Impact factor: 1.880

5.  The function of α-synuclein.

Authors:  Jacob T Bendor; Todd P Logan; Robert H Edwards
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

6.  Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling.

Authors:  Tziona Ben Gedalya; Virginie Loeb; Eitan Israeli; Yoram Altschuler; Dennis J Selkoe; Ronit Sharon
Journal:  Traffic       Date:  2008-10-31       Impact factor: 6.215

7.  Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype.

Authors:  Irit Rappley; David S Myers; Stephen B Milne; Pavlina T Ivanova; Matthew J Lavoie; H Alex Brown; Dennis J Selkoe
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

8.  Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression.

Authors:  Adam Jangula; Eric J Murphy
Journal:  Neurosci Lett       Date:  2013-07-19       Impact factor: 3.046

Review 9.  alpha-Synuclein: a therapeutic target for Parkinson's disease?

Authors:  Kathleen A Maguire-Zeiss
Journal:  Pharmacol Res       Date:  2008-09-16       Impact factor: 7.658

10.  Coding mutations in NUS1 contribute to Parkinson's disease.

Authors:  Ji-Feng Guo; Lu Zhang; Kai Li; Jun-Pu Mei; Jin Xue; Jia Chen; Xia Tang; Lu Shen; Hong Jiang; Chao Chen; Hui Guo; Xue-Li Wu; Si-Long Sun; Qian Xu; Qi-Ying Sun; Piu Chan; Hui-Fang Shang; Tao Wang; Guo-Hua Zhao; Jing-Yu Liu; Xue-Feng Xie; Yi-Qi Jiang; Zhen-Hua Liu; Yu-Wen Zhao; Zuo-Bin Zhu; Jia-da Li; Zheng-Mao Hu; Xin-Xiang Yan; Xiao-Dong Fang; Guang-Hui Wang; Feng-Yu Zhang; Kun Xia; Chun-Yu Liu; Xiong-Wei Zhu; Zhen-Yu Yue; Shuai Cheng Li; Huai-Bin Cai; Zhuo-Hua Zhang; Ran-Hui Duan; Bei-Sha Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.